Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV, West Nile virus, SARS – infections and thoracic transplantation

21.04.2004


Two largest organ transplant societies join forces to tackle problem of traditional and exotic infections in thoracic transplantation

Complications from infectious diseases, such as HIV and West Nile virus in heart and lung transplant patients, is the focus of a joint symposium at the International Society for Heart and Lung Transplantation (ISHLT) 24th Annual Meeting held in San Francisco.

When demand for organs continually outstrips supply, offering transplants to patients with infectious diseases, such as HIV, remains controversial. For those needing heart and lung transplants, it’s not only controversial but somewhat uncharted territory. Only in the last few years have organ transplants even been offered to HIV-positive patients, much less performed; and most of the procedures have been liver and kidney transplants.



"While there are no prospective data in heart and lung transplantation, this is an area that merits careful investigation," said Jay A. Fishman, M.D., Infectious Disease Division, Massachusetts General Hospital and Harvard Medical School. "Recent data suggest that transplantation can be safely performed in selected individuals infected with HIV if viral infection can be controlled by highly-active anti-retroviral therapy."

Managing anti-rejection drugs and anti-retroviral therapies presents quite a challenge. Transplant teams must achieve just the right balance between the two types of drugs because of interactions and toxicity. Suppressing the immune system too much with high doses of the anti-rejection drug may allow a viral infection to worsen; too low a dose and the organ may be rejected.

In an effort to advance the science and treatment of heart and lung transplantation in patients affected by infectious disease, the ISHLT together with the American Society of Transplantation (AST), is sponsoring a joint symposium for the first time. Research and commentary is being presented and discussed by experts from around the globe on:
  • HIV in transplantation
  • Experiences with SARS and West Nile virus
  • Infections of left ventricular assist devices (LVADs) and other devices
  • Hepatitis viruses in transplantation
  • Fungal infections in thoracic transplantation

In addition to traditional viral infections, such as herpes, hepatitis C and influenza, "exotic" infections like SARS and West Nile virus are becoming a major problem for transplant recipients. These infections may have direct effects contributing to morbidity and mortality, as well as indirect effects resulting in organ dysfunction and loss.

Atul Humar, M.D. from the University of Toronto, Canada, is presenting SARS and West Nile virus as emerging infectious diseases in transplantation. Although most infections in the general population are asymptomatic, little is known about the consequences of infection in transplant recipients.

"Efforts aimed at improving our understanding of the diagnosis, natural history, prevention and treatment of these infections will lead to improved transplant organ and patient survival," said Dr. Humar.


About ISHLT The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. Created in 1981 at a gathering of about 15 cardiologists and cardiac surgeons, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT maintains two databases. The International Heart and Lung Transplant Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries. The ISHLT Mechanical Circulatory Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation; generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices.

Kelly Goff | EurekAlert!
Further information:
http://www.ishlt.org/

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>